Plaque Psoriasis Clinical Trials in Shanghai, Shanghai Municipality
6 recruitingShanghai, Shanghai Municipality, China
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Bristol-Myers Squibb366 enrolled120 locationsNCT06979453
Recruiting
Phase 3
A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
InventisBio Co., Ltd477 enrolled1 locationNCT07326813
Recruiting
Phase 3
Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis Patients
Beijing InnoCare Pharma Tech Co., Ltd.383 enrolled46 locationsNCT06842199
Recruiting
Phase 3
A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects
Plaque Psoriasis
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.537 enrolled55 locationsNCT07357831
Recruiting
A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China
Plaque Psoriasis
Bristol-Myers Squibb150 enrolled5 locationsNCT06512337
Recruiting
Phase 2
Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Beijing InnoCare Pharma Tech Co., Ltd.172 enrolled1 locationNCT07251998